Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) PET/CT and Ultrasound in Staging of Patients With Malignant Melanoma: An Analysis in a Single Patient Population

NCT04253574 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT04253574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04253574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) PET/CT and Ultrasound in Staging of Patients With Malignant Melanoma: An Analysis in a Single Patient Population
Lead sponsor
University of Basel
Phase
Observational
Overall status
Completed
Start date
September 1, 2014
Completion date
September 1, 2018
Enrollment
258 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma